Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

OCRL Rabbit Polyclonal Antibody

Product Specifications

Background

This gene encodes an inositol polyphosphate 5-phosphatase. This protein is involved in regulating membrane trafficking and is located in numerous subcellular locations including the trans-Golgi network, clathrin-coated vesicles and, endosomes and the plasma membrane. This protein may also play a role in primary cilium formation. Mutations in this gene cause oculocerebrorenal syndrome of Lowe and also Dent disease. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016], catalytic activity:1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H (2) O = 1-phosphatidyl-1D-myo-inositol 4-phosphate + phosphate., caution:It is uncertain whether Met-1, Met-18 or Met-20 is the initiator., disease:Defects in OCRL are the cause of Dent disease type 2 (DD2) [MIM:300555]. DD2 is a renal disease belonging to the 'Dent disease complex', a group of disorders characterized by proximal renal tubular defect, hypercalciuria, nephrocalcinosis, and renal insufficiency. The spectrum of phenotypic features is remarkably similar in the various disorders, except for differences in the severity of bone deformities and renal impairment. Characteristic abnormalities include low-molecular-weight proteinuria and other features of Fanconi syndrome, such as glycosuria, aminoaciduria, and phosphaturia, but typically do not include proximal renal tubular acidosis. Progressive renal failure is common, as are nephrocalcinosis and kidney stones., disease:Defects in OCRL are the cause of Lowe syndrome [MIM:309000]; also known as Lowe oculocerebrorenal syndrome. The Lowe syndrome is an X-linked multisystem disorder affecting eyes, nervous system, and kidney. It is characterized by hydrophthalmia, cataract, mental retardation, vitamin D-resistant rickets, aminoaciduria, and reduced ammonia production by the kidney. Ocular abnormalities include cataract, glaucoma, microphthalmos, and decreased visual acuity. Developmental delay, hypotonia, behavior abnormalities, and areflexia are also present. Renal tubular involvement is characterized by impaired reabsorption of bicarbonate, amino acids, and phosphate. Musculoskeletal abnormalities such as joint hypermobility, dislocated hips, and fractures may develop as consequences of renal tubular acidosis and hypophosphatemia. Cataract is the only significant manifestation in carriers and is detected by slit-lamp examination., function:Converts phosphatidylinositol 4,5-bisphosphate to phosphatidylinositol 4-phosphate. Also converts inositol 1,4,5-trisphosphate to inositol 1,4-bisphosphate and inositol 1,3,4,5-tetrakisphosphate to inositol 1,3,4-trisphosphate. May function in lysosomal membrane trafficking by regulating the specific pool of phosphatidylinositol 4,5-bisphosphate that is associated with lysosomes., similarity:Belongs to the inositol-1,4,5-trisphosphate 5-phosphatase type II family., similarity:Contains 1 Rho-GAP domain., tissue specificity:Brain, skeletal muscle, heart, kidney, lung, placenta and fibroblasts.

Product Name Alternative

OCRL; INPP5F; OCRL1; Inositol polyphosphate 5-phosphatase OCRL-1; Lowe oculocerebrorenal syndrome protein

Gene Name

OCRL

Gene ID

4952

Swiss Prot

Q01968

Host

Rabbit

Reactivity

Human, Mouse

Clonality

Polyclonal

Conjugation

Unconjugated

Applications

WB, ELISA

Field of Research

Inositol phosphate metabolism; Phosphatidylinositol signaling system

Purification

Affinity purification

Dilution

WB 1:500-1:2000, ELISA 1:5000-1:20000

Form

Liquid

Buffer

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% New type preservative N.

Modification

Unmodified

Molecular Weight

104kDa

Storage Conditions

Store at 4°C short term. Aliquot and store at -20°C for 12 months. Avoid freeze/thaw cycles.

Isotype

IgG

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CDC42EP2, CT (CDC42EP2, BORG1, CEP2, Cdc42 effector protein 2, Binder of Rho GTPases 1) (MaxLight 750) discontinued
033600-ML750 100 µL

CDC42EP2, CT (CDC42EP2, BORG1, CEP2, Cdc42 effector protein 2, Binder of Rho GTPases 1) (MaxLight 750) discontinued

Sign In for Pricing
View Details
5-Methoxyisoindoline-1,3-dione
436882-01 50 mg

5-Methoxyisoindoline-1,3-dione

Sign In for Pricing
View Details
5-Methoxyisoindoline-1,3-dione
436882-02 100 mg

5-Methoxyisoindoline-1,3-dione

Sign In for Pricing
View Details
Cytomegalovirus, Human, p65 IE (Immediate Early) (CMV) (MaxLight 405) discontinued
C9100-15A-ML405 100 µL

Cytomegalovirus, Human, p65 IE (Immediate Early) (CMV) (MaxLight 405) discontinued

Sign In for Pricing
View Details
Recombinant Staphylococcus aureus Phosphate-binding protein pstS (pstS)
MBS1483465-01 0.02 mg (E-Coli)

Recombinant Staphylococcus aureus Phosphate-binding protein pstS (pstS)

Sign In for Pricing
View Details
Recombinant Staphylococcus aureus Phosphate-binding protein pstS (pstS)
MBS1483465-02 0.02 mg (Yeast)

Recombinant Staphylococcus aureus Phosphate-binding protein pstS (pstS)

Sign In for Pricing
View Details